biosyngen.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: | ||
Meta Tags
| Title | Biosyngen |
| Description | Giving cancer patients a second MENU Giving cancer patients a second chance The complexity of cancer demands a targeted approach to give patients their best shot at remission. We design |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | |
| Location |
Related Websites
| Site | Rank |
More to Explore
biosyngen.com Valuation
|
US$355,798
Last updated: 2023-05-10 23:35:20
biosyngen.com has Semrush global rank of 29,748,137. biosyngen.com has an estimated worth of US$ 355,798, based on its estimated Ads revenue. biosyngen.com receives approximately 41,054 unique visitors each day. Its web server is located in , with IP address . According to SiteAdvisor, biosyngen.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$355,798 |
| Daily Ads Revenue | US$329 |
| Monthly Ads Revenue | US$9,853 |
| Yearly Ads Revenue | US$118,235 |
| Daily Unique Visitors | 2,737 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| biosyngen.com. | NS | 86400 | NS Record: dns16.hichina.com. |
| biosyngen.com. | NS | 86400 | NS Record: dns15.hichina.com. |
| biosyngen.com. | MX | 600 | MX Record: 10 biosyngen-com.mail.protection.outlook.com. |
| biosyngen.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| biosyngen.com. | TXT | 600 | TXT Record: MS=ms66240642 |
| biosyngen.com. | TXT | 600 | TXT Record: google-site-verification=NOWxFTJAByZ1JkLkdP0Mm8RIrqq1RaSTSA_xCaHBb8E |
HtmlToTextCheckTime:2023-05-10 23:35:20
| MENU Giving cancer patients a second chance The complexity of cancer demands a targeted approach to give patients their best shot at remission. We design cutting-edge immunotherapies to meet these needs. LEARN MORE Technology Taking targeted cancer treatment to the next level. BioSyngen is utilizing our proprietary EBV platform to develop next-generation CAR-T and TCR-T therapies to target EBV related cancers. In activating a strong immune response, our therapies not only destroy cancer cells but also critically reduce off-target or on target off tumor toxicities to preserve healthy cells,—ensuring enhanced safety and clinical efficacy in tandem. Distinct approach to T-cell therapies. Taking aim at EBV antigens. Epstein-Barr virus (EBV) related cancers are prevalent in Asia, yet most current therapies do not target such viral antigens. We are one of the few biotechs filling this gap in tumor immunotherapy. Breaking barriers in treating solid tumors. Our therapies can effectively attack |
biosyngen.com Whois Information
Domain Name: BIOSYNGEN.COM Registry Domain ID: 2164672028_DOMAIN_COM-VRSN Registrar WHOIS Server: grs-whois.hichina.com Registrar URL: http://www.net.cn Updated Date: 2021-08-22T06:24:39Z Creation Date: 2017-09-18T19:55:58Z Registry Expiry Date: 2024-09-18T19:55:58Z Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd. Registrar IANA ID: 420 Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com Registrar Abuse Contact Phone: +86.95187 Domain Status: ok https://icann.org/epp#ok Name Server: DNS15.HICHINA.COM Name Server: DNS16.HICHINA.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-09T07:13:07Z <<< |